Amman: Russia’s National Medical Research Radiological Centre (NMRRC), affiliated with the Ministry of Health, has officially launched the first phase of clinical trials for a new anti-cancer vaccine called EnteroMix, the center announced on Saturday.
According to Jordan News Agency, NMRRC’s Director General Andrey Kaprin spoke at the St. Petersburg International Economic Forum, stating, “We have already begun the first open-label, single-center phase of clinical testing for this vaccine, which has demonstrated very low toxicity levels.”
Kaprin further explained that EnteroMix is based on four non-pathogenic viruses capable of destroying malignant tumors while simultaneously activating the patient’s anti-tumor immune response. “The vaccine’s effects range from slowing tumor growth to complete destruction of the cancer,” he added.